-
Guggenheim Reiterates "Buy" Rating for ORIC Pharmaceuticals (NASDAQ:ORIC)
Source: Buzz FX / 10 Feb 2025 08:26:10 America/Chicago
Guggenheim Reiterates "Buy" Rating for ORIC Pharmaceuticals (NASDAQ:ORIC) Written by MarketBeat February 10, 2025 Share Link copied to clipboard. ORIC Pharmaceuticals ( NASDAQ:ORIC - Get Free Report ) 's stock had its "buy" rating restated
Read more...